Egetis Therapeutics AB
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.
Egetis Therapeutics AB has raised $65.0M across 2 rounds. Its most recent round was a Series Unknown of $38.3M in Apr 2026. Full funding history, investors, and team are detailed below.
Funding history
2 rounds on record — latest round shown, the rest unlock with a paid plan.
Unlock 1 earlier round — dates, amounts, round types — plus the lead investor for every round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Egetis Therapeutics AB is featured in
Similar companies
India Globalization Capital, Inc. (IGC) operates as a materials and infrastructure company in India and China. In India, the Company is engaged in supplying and trading iron ore and in leasing construction equipment, and to a lesser extent constructing roads, highways and supply rock aggregate. In June 2014, the Company acquired 51% interest of Golden Gate Electronics Limited.
Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced treatment options for patients.
LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription medicines. Our main program is an eye drop with aceclidine to treat presbyopia-related loss of near vision. More than 120 million people in the US and about two billion people worldwide are affected by presbyopia. LENZ Therapeutics is based in San Diego, California, and is supported by a number of prestigious venture capitalists.
MiMove is a different kind of property portal. We are a regulated marketplace. That means that we visit and vet all real estate agencies before they can post their properties on MiMove – and exclude agencies who do not follow our rules. That is why we dare say that we are the safest marketplace for properties abroad.
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.
Nivika är ett Småländskt fastighetsbolag som förvärvar, förvaltar och utvecklar fastigheter primärt på expansiva orter i med en stabil hyresmarknad i södra Sverige. Vi är ett starkt team som med närhet, hög servicegrad och kvalitet bygger långsiktiga och starka kundrelationer. Vår arbetskultur präglas av starkt engagemang, glädje och ärlighet där korta beslutsvägar och entreprenöriell anda är hörnstenar. Det är mycket viktigt för oss att bibehålla den familjära stämningen med möjlighet för alla medarbetare att vara delaktiga på olika sätt.
Metacon AB is a hydrogen energy systems provider that develops and manufactures energy systems for hydrogen, heat, and electricity production using catalytic steam reforming technology to generate hydrogen from biogas or hydrocarbons. Metacon also offers electrolysis systems and hydrogen refuelling solutions.
Tech development. Model driven tech. DTO. Digital Twin of an Organization. Solution areas are End-to-End Product Management, CIO Excellence, Growth and Innovation Management, Corporate Governance and Development
Wayout offers an environmentally friendly, plug-and-play drinking water system that is locally sourced. It is 100% plastic-free and has a naturally balanced pH and mineral composition.
is building a video-first hiring platform that combines AI interview agents with short-form video profiles.
Sportway is an online network that enables young athletes to meet and share experiences.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.